心臓代謝疾患市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00025374
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 293
Buy Now

心臓代謝疾患市場は、2021 年の 934 億 9,441 万米ドルから、2028 年までに 1,218 億 449 万米ドルに達すると予想されています。 2021 年から 2028 年にかけて CAGR は 3.9% で増加すると推定されています。



心血管疾患は、心血管疾患を発症するリスクを高める一連の異常や症状によって特徴付けられます。高血圧、肥満、インスリン抵抗性、脂質異常症、コレステロールプロファイル(LDL)低下、および耐糖能は、心臓代謝性疾患のいくつかの症状です。心メタボリックシンドロームに罹患している人は、2 型糖尿病、脳卒中、冠動脈疾患 (CAD)、心血管疾患 (CVD) など、他の多くの生命を脅かす病気にかかりやすいです。遺伝的条件と環境条件の両方が疾患の発症に関与しています。



戦略的洞察



心臓代謝疾患市場の成長は、主に心臓代謝疾患の有病率の増加や心臓代謝疾患のイノベーションなどの要因に起因しています。 CMD治療薬。しかし、低中所得国 (LMIC) における CVD の過少診断が市場の成長を妨げています。



心臓代謝疾患市場の有利な地域



市場洞察心臓代謝疾患の有病率の増加



心臓代謝性疾患 (CMD) は、世界中で主な死因の 1 つです。これらの病気は主に、不健康なライフスタイル、運動不足、喫煙、不健康な食生活によって引き起こされます。 CMD には、心血管疾患 (CVD)、糖尿病、および慢性腎不全が含まれます。 WHO によると、2019 年には約 1,790 万人が CVD で死亡し、これは世界全体の死亡者数の 32% に相当します。これらの死亡のうち、85% は心臓発作と脳卒中によるものでした。

ほとんどの心血管疾患は、喫煙、不健康な食事の選択、肥満、運動不足、アルコール摂取などの行動危険因子に対処することで予防できます。糖尿病は、機能的な治療法のない、生命を脅かす慢性疾患の 1 つです。それはさまざまな合併症を引き起こし、早期死亡の全体的なリスクを高めます。心臓発作、脳卒中、腎不全、下肢切断、視力喪失、神経損傷は、糖尿病に関連する主な合併症です。国際糖尿病連盟 (IDF) によると、2019 年には約 4 億 6,300 万人の成人が糖尿病を抱えており、2045 年までに 7 億人に達すると予想されています。



糖尿病患者の数は世界的に増加しています。喫煙、運動不足、アルコール摂取、不健康な食生活の増加による1つ以上のCMD。 WHO の 2021 年 7 月の統計によると、毎年 800 万人以上がタバコの摂取により死亡しています。その消費は低所得国および中所得国で多く、世界の消費者ベースの 80% がこれらの国に住んでいます。肥満の有病率の増加により、CMD に苦しむ患者層も増加しています。 CMD の有病率の急速な上昇により、適切な心臓代謝疾患治療のニーズが急増し、その結果、市場が大幅に成長しました。



タイプベースの洞察



心臓代謝疾患市場は、タイプ別に、心血管疾患(CVD)、高血圧、2 型糖尿病、肥満に分類されます。心血管疾患 (CVD) セグメントは 2021 年に市場で最大のシェアを占め、このセグメントは予測期間中に市場で最高の CAGR を記録すると予想されます。



心血管疾患市場、タイプ別 - 2021



治療ベースの洞察



心臓代謝疾患市場は治療ごとに、ACE阻害剤、利尿薬、グルコファージなどに分類されます。 ACE 阻害剤セグメントは 2021 年の市場で最大のシェアを保持しており、同セグメントは予測期間中に市場で最高の CAGR を記録すると予想されます。



用量ベースの洞察



心臓代謝疾患市場は、用量別に錠剤と注射剤に分かれています。タブレットセグメントは 2021 年に大きな市場シェアを保持しており、予測期間中に市場でより高い CAGR を記録すると予想されます。



投与ベースの洞察のルート



心臓代謝疾患市場は投与経路により経口投与と静脈内投与に分かれます。 2021 年には、経口セグメントが市場でより大きなシェアを占め、今後数年間でより高い CAGR を記録すると予想されます。



エンドユーザーベースの洞察



心臓代謝疾患市場、エンドユーザーごとに、診療所、病院、在宅医療環境に分類されます。 2021 年には、病院セグメントが市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると予想されています。



製品の発売と承認は、企業が世界展開するために一般的に採用する戦略です。フットプリントと製品ポートフォリオ。さらに、研究所が開発した検査市場のプレーヤーは、顧客層を拡大するためのパートナーシップ戦略に焦点を当てており、それによってブランド名を世界的に維持することが可能になります。



レポートは、心臓代謝疾患市場を次のように分類しています。

心臓代謝疾患市場は、種類に基づいて、心血管疾患 (CVD)、高血圧、2 型糖尿病、肥満に分類されます。治療に基づいて、市場はACE阻害剤、利尿剤、グルコファージなどに分類されます。用量に基づいて、心臓代謝疾患市場は錠剤と注射剤に二分されます。投与経路に基づいて、市場は経口投与と静脈内投与に分かれます。エンドユーザーに基づいて、心臓代謝疾患市場は診療所、病院、在宅医療環境に分類されます。市場は地理的に、北米(米国、カナダ、メキシコ)、ヨーロッパ(英国、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ)、アジア太平洋(中国、日本、インド、オーストラリア)に分割されています。 、韓国、およびその他のアジア太平洋地域)、中東およびアフリカ(UAE、サウジアラビア、南アフリカ、およびその他の中東およびアフリカ)、中南米(ブラジル、アルゼンチン、および



会社概要





  • Eli Lilly and Company

  • Bayer AG

  • Arrowhead Pharmaceuticals、 Inc

  • Novartis AG

  • Boehringer Ingelheim International GmbH

  • Novo Nordisk A/S

  • AstraZeneca

  • Alnylam Pharmaceuticals 、株式会社

  • カーダックス株式会社

  • 興和株式会社


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is cardiometabolic diseases market?

Cardiometabolic disease is characterized by a group of abnormalities and symptoms that raise the risk of individuals developing cardiovascular disease. Hypertension, obesity, insulin resistance, dyslipidemia, poor cholesterol profile (LDL), and glucose tolerance are a few symptoms of cardiometabolic diseases. Individuals suffering from cardiometabolic syndrome are prone to many other life-threatening diseases, such as type 2 diabetes, stroke, coronary artery disease (CAD), and cardiovascular disease (CVD). Both genetic and environmental conditions are responsible for the development of the diseases.

What are the driving factors for the cardiometabolic diseases market across the country?

The factors that are driving and restraining factors that will affect cardiometabolic diseases market in the coming years. Factors such as increasing prevalence of cardiometabolic diseases and innovation in CMDs therapeutics. However, underdiagnosis of CVDs in low- and middle-income countries (LMICs) is hampering the growth of the market.

Who are the major players in the cardiometabolic diseases market?

The cardiometabolic diseases market majorly consists of the players such as as Eli Lilly and Company; Bayer AG; Arrowhead Pharmaceuticals, Inc; Novartis AG; Boehringer Ingelheim International GmbH; Novo Nordisk A/S; AstraZeneca; Alnylam Pharmaceuticals, Inc.; Cardax, Inc.; and Kowa Company, Ltd among others.

Which segment is dominating the cardiometabolic diseases market?

The global cardiometabolic diseases market cardiovascular disease (CVD), hypertension, type 2 diabetes, and obesity. The cardiovascular disease (CVD) segment is expected to hold the largest share and register the highest CAGR in the market during the forecast period.

The List of Companies - Cardiometabolic Diseases Market

  1. Eli Lilly and Company
  2. Bayer AG
  3. Arrowhead Pharmaceuticals, Inc
  4. Novartis AG
  5. Boehringer Ingelheim International GmbH
  6. Novo Nordisk A/S
  7. AstraZeneca
  8. Alnylam Pharmaceuticals, Inc.
  9. Cardax, Inc
  10. Kowa Company, Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports